MoneyWorks4Me

The company witnessed a 20.49% growth in the revenue at Rs. 159.37 millions for the quarter ended December 2021 as compared to Rs. 132.27 millions during the year-ago period.Profit after Tax for the quarter ended December 2021 saw a decline of -48.62% from Rs. 1.09 millions to Rs. 0.56  millions.Operating profit for the quarter ended December 2021 decreased to 14.27 millions as compared to 16.10 millions of corresponding quarter ended December 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 159.37 132.27 20.49 527.12 420.86 25.25 560.15 484.12 15.70
Other Income 0.97 0.73 32.88 1.90 3.41 -44.28 5.85 3.91 49.62
PBIDT 14.27 16.10 -11.37 72.60 67.96 6.83 88.17 84.80 3.97
Interest 4.29 5.71 -24.87 14.82 16.31 -9.14 22.06 15.12 45.90
PBDT 9.98 10.39 -3.95 57.78 51.65 11.87 66.11 69.68 -5.12
Depreciation 9.23 8.93 3.36 25.83 26.31 -1.82 35.11 30.22 16.18
PBT 0.75 1.46 -48.63 31.95 25.34 26.09 31.00 39.46 -21.44
TAX 0.19 0.37 -48.65 7.99 6.34 26.03 7.75 10.60 -26.89
Deferred Tax 0.37 0.65 -43.08 2.31 1.82 26.92 2.46 3.50 -29.71
PAT 0.56 1.09 -48.62 23.96 19.00 26.11 23.25 28.86 -19.44
Equity 54.85 54.85 0.00 54.85 54.85 0.00 54.85 54.85 0.00
PBIDTM(%) 8.95 12.17 -26.44 13.77 16.15 -14.71 15.74 17.52 -10.14
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..